HYDROCORTISONE SODIUM SUCCINATE
Generic: HYDROCORTISONE SODIUM SUCCINATE
Cipla USA Inc.Manufacturer
INTRAMUSCULAR, INTRAVENOUSRoute
HYDROCORTISONE SODIUM SUCCINATEActive Substance
2024-09-05Original Approval
HYDROCORTISONE SODIUM SUCCINATE is FDA application ANDA214050, sponsored by CIPLA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
OFF LABEL USE
819 reports
2
RASH
691 reports
3
HYPERSENSITIVITY
689 reports
4
FATIGUE
686 reports
5
INFUSION RELATED REACTION
684 reports
6
PYREXIA
674 reports
7
HYPERTENSION
642 reports
8
INFECTION
625 reports
9
WOUND
624 reports
10
PAIN
610 reports